Paper Details

  1. Home
  2. Paper Details

Effects of CYP3A inhibitors ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of sunitinib and its main metabolite in rats.

Author: ChenRui-Jie, ChengChen, CuiXiao, HuangCheng-Ke, SunWei, WangJun, WangYi, WangZhe

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

CYP3A inhibitors, such as ketoconazole and voriconazole, can significantly increase the exposure of sunitinib and decrease the exposure of its metabolite N-desethyl sunitinib. This interaction should be considered when sunitinib is coadministered with CYP3A inhibitors.
Paper Details　
Original Abstract of the Article :
Sunitinib is a small molecule inhibitor of multiple receptor tyrosine kinases such as platelet derived growth factor receptor, vascular endothelial growth factor receptor, kit receptor and other receptors. The US Food and Drug Administration (FDA) has approved sunitinib for the treatment of advanced...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.cbi.2021.109426

データ提供：米国国立医学図書館（NLM）

Sunitinib and CYP3A Inhibitors: A Desert of Drug Interactions

The world of drug interactions can be a complex and confusing desert, filled with potential pitfalls. This study, like a careful camel navigating a treacherous landscape, investigates the potential interactions between sunitinib, a cancer drug, and CYP3A inhibitors, a class of medications that can affect drug metabolism. The researchers, using Sprague Dawley rats, found that ketoconazole and voriconazole, two CYP3A inhibitors, significantly increased the exposure of sunitinib and inhibited its metabolism. These findings highlight the importance of understanding drug interactions to avoid potential toxicity.

Navigating the Desert of Drug Interactions: A Guide to Safe Medication

This study reveals a critical interaction between sunitinib and certain CYP3A inhibitors. The study found that ketoconazole and voriconazole can significantly increase the levels of sunitinib, potentially leading to toxicity. This knowledge underscores the importance of consulting with healthcare professionals about potential drug interactions before taking any new medications.

Balancing Health and Medication: A Desert Oasis of Information

The study emphasizes the importance of understanding drug interactions to ensure safe and effective treatment. It reminds us that, just as a wise camel navigates a desert landscape, we must be cautious and informed when considering medications. Consulting with healthcare professionals is essential for navigating the complex world of drug interactions and ensuring the safety of our health.

Dr. Camel's Conclusion

This study serves as a reminder that the world of drug interactions can be a vast and sometimes dangerous desert. Being aware of potential interactions and consulting with healthcare professionals are key to navigating this complex landscape safely and effectively.

Date :
  1. Date Completed 2021-03-24
  2. Date Revised 2021-03-24
Further Info :

Pubmed ID

33617800

DOI: Digital Object Identifier

10.1016/j.cbi.2021.109426

Related Literature

Article Analysis
・Effects of voriconazole・Effects of sunitinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.